ArticleOncotarget2019

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.

Qiang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.